View the latest news, publications, and awards from our team.
Fox News highlights the Kumar Lab’s development of a next-generation tetra-receptor agonist designed to enhance weight loss while potentially reducing side effects associated with current GLP-1 therapies.
Read the Fox News coverage →
The American Peptide Society highlights Kumar Lab research demonstrating how N-terminal modifications can tune receptor balance and signaling bias in unimolecular incretin multiagonists.
Read the coverage →
Phys.org features Kumar Lab research on a unimolecular tetra-receptor agonist designed to enhance weight loss while reducing side effects.
Read the coverage →
Tufts Now highlights Kumar Lab research exploring if lipid-linked peptides named pepducins can modulate receptor activity from inside the cell membrane.
Read the coverage →
News-Medical features Kumar Lab research on a unimolecular tetra-receptor agonist designed with the goal of improving future obesity therapeutics.
Read the coverage →
ScienceDaily highlights Kumar Lab research on a unimolecular tetra-receptor agonist peptide designed to push next-generation weight-loss therapeutics closer to the effectiveness associated with bariatric surgery.
Read the coverage →
The Express Gazette highlights Kumar Lab research on a peptide designed to activate GLP-1, GIP, glucagon, and PYY pathways in a single molecule.
Read the coverage →